By showing a critical role for sialylation in the biophysical properties of mucus and mucus transport, the study identifies a possible therapeutic target for the treatment of cystic fibrosis and other muco-obstructive diseases.

Linda Morgan’s transplant journey has inspired many and will continue to do so as she shares her story with the world.

This live biotherapeutic product, tested in mouse models, shows promise in addressing common pathways of lung disease progression.

Chronic obstructive pulmonary disease patients with type 2 inflammation saw rapid and sustained improvements after treatment with the monoclonal antibody dupilumab.

UAB experts says that individuals can prevent or decrease symptoms of sleep apnea by making small lifestyle changes.

Cigarette smoking is associated with COPD, and each cigarette has 2 to 3 micrograms of cadmium.

Vivek Lal, M.D., associate professor in the Department of Pediatrics at UAB Heersink School of Medicine and the founder of both ResBiotic Nutrition and Alveolus Bio, was given the 2023 Award for Excellence in Entrepreneurship.

The Blazer Bridge Fund is intended to identify and assist in the development of promising ideas, discoveries, innovations and/or technologies from UAB faculty and staff that have commercial potential. 

Chronic obstructive pulmonary disease patients with type 2 inflammation saw rapid and sustained improvements in their disease after treatment with the monoclonal antibody dupilumab.

Description of this mechanism offers a promising therapeutic target to limit lung injury and death. Lower respiratory tract infections, including bacterial pneumonia, are the fourth-leading cause of death worldwide, with 120 million to 156 million cases and 1.4 million deaths a year.

Having a bacterial infection at the same time as COVID-19 is a greater risk factor for COVID-19 severity and mortality than previously described risk factors such as advanced age, male sex or various comorbidities.

New screening guidelines and improvements in diagnostics and treatment have improved outcomes in lung cancer.

Record $95 million Heersink lead gift to advance strategic growth and biomedical innovation.

A Bcl-2 inhibitor that has FDA approval for treatment of several leukemias reversed lung fibrosis in a bleomycin mouse model.

A new multidisciplinary program within UAB Medicine will help evaluate patients who have recovered from COVID-19 but are still experiencing symptoms and link them to the specialized care they need.

Alabama is one of 10 U.S. states with the highest rates of short sleep duration.

This study was done in mice and with a novel, tissue-engineered, three-dimensional breast cancer mimetic system.

This study included preclinical experiments and use of bronchoalveolar cells from IPF patients.

Airway fractal dimension gives added prognostic information over traditional CT scan measures in COPD.

A diabetes drug suggests potential therapy for idiopathic pulmonary fibrosis, based on research with human lung fibroblasts and a mouse model of lung fibrosis.